Olaplex IPO Presentation Deck

Superior Growth and Margin Profile 2020A EBITDA Margin 80.0 % 70.0 % 60.0% 50.0 % 40.0 % 30.0 % 20.0% 10.0% 0.0% (10)% OLAPLEX Net Sales Growth vs. Adjusted EBITDA Margin for All Companies in the S&P 500 10% 20% 30% 50% 40% '19A - '20A Revenue Growth 60% 70% OLAPLEX. 80% 90% 100% Source: Capital IQ, IBES (as of Jul-2021) Note: Analysis includes all companies currently listed in the S&P 500. For a reconciliation of Adjusted EBITDA to income (loss) from operations, please refer to the appendix of this presentation. 19

View entire presentation